Users of the nasal spray form of the drug have reported side effects such as headaches, dizziness, panic attacks, nausea, vomiting, facial flushing, unusual moles, and more
However, iGlarLixi patients had more gastrointestinal-related adverse, primarily nausea (16.9% vs
This stability allows for different BPC-157 delivery methods that arent possible with other peptides
This is particularly important given the variable blood pressure effects different users experience
In fact, it's central to our discussion about blood pressure
The conversion of riboflavin into the active cofactor forms FAD and FMN is impaired in hypothyroidism and adrenal insufficiency (3, 4)